Ion Channels as Targets in Drug Discovery



de

,

Éditeur :

Springer


Paru le : 2024-04-24



eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Lecture en ligne (streaming)
210,99

Téléchargement immédiat
Dès validation de votre commande
Ajouter à ma liste d'envies
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description
This book is built around ion channel research and, more specifically, ion channels as important therapeutic drug targets. Under the editorial leadership of Gary Stephens in academic research and Edward Stevens from industry, the aim is to bring these strands together to provide a cutting-edge translational reference on ion channel drug discovery.  Exploiting our knowledge of ion channel structure and function has clear current and future potential to intervene and correct the pathophysiology associated with debilitating conditions, including cardiovascular disease, diabetes, cystic fibrosis, pain, epilepsy, and neurodegenerative disorders. Individual chapters have a disease focus, also providing a “case study story” that will also appeal to a clinical audience, while background information on a given ion channel is presented to provide a solid reference for undergraduate and postgraduate teaching.
Pages
537 pages
Collection
n.c
Parution
2024-04-24
Marque
Springer
EAN papier
9783031521966
EAN PDF
9783031521973

Informations sur l'ebook
Nombre pages copiables
5
Nombre pages imprimables
53
Taille du fichier
25948 Ko
Prix
210,99 €
EAN EPUB
9783031521973

Informations sur l'ebook
Nombre pages copiables
5
Nombre pages imprimables
53
Taille du fichier
37089 Ko
Prix
210,99 €

Gary Stephens is Professor of Pharmacology at the School of Pharmacy, University of Reading, United Kingdom.  He is an in vitro electrophysiologist with an interest in voltage-gated calcium channels and G protein-coupled receptors.  He is a Senior Editor with the British Journal of Pharmacology and is on the Editorial Board of Pharmaceuticals.


Edward Stevens is Chief Scientific Officer at Metrion Biosciences and has over 20 years’ experience of ion channel drug discovery within the biotech/pharma field.

Suggestions personnalisées